全文获取类型
收费全文 | 290889篇 |
免费 | 39500篇 |
国内免费 | 3312篇 |
专业分类
耳鼻咽喉 | 6546篇 |
儿科学 | 9430篇 |
妇产科学 | 5951篇 |
基础医学 | 22913篇 |
口腔科学 | 6799篇 |
临床医学 | 38831篇 |
内科学 | 80450篇 |
皮肤病学 | 10632篇 |
神经病学 | 27971篇 |
特种医学 | 9707篇 |
外国民族医学 | 1篇 |
外科学 | 55841篇 |
综合类 | 795篇 |
现状与发展 | 72篇 |
一般理论 | 59篇 |
预防医学 | 19488篇 |
眼科学 | 5682篇 |
药学 | 10486篇 |
中国医学 | 529篇 |
肿瘤学 | 21518篇 |
出版年
2024年 | 601篇 |
2023年 | 5750篇 |
2022年 | 3439篇 |
2021年 | 7780篇 |
2020年 | 8684篇 |
2019年 | 6086篇 |
2018年 | 11913篇 |
2017年 | 10534篇 |
2016年 | 12110篇 |
2015年 | 12609篇 |
2014年 | 21128篇 |
2013年 | 23178篇 |
2012年 | 17338篇 |
2011年 | 17607篇 |
2010年 | 16824篇 |
2009年 | 19599篇 |
2008年 | 15600篇 |
2007年 | 14042篇 |
2006年 | 15670篇 |
2005年 | 12518篇 |
2004年 | 10901篇 |
2003年 | 9045篇 |
2002年 | 8386篇 |
2001年 | 4592篇 |
2000年 | 3598篇 |
1999年 | 4064篇 |
1998年 | 4728篇 |
1997年 | 4333篇 |
1996年 | 4098篇 |
1995年 | 3887篇 |
1994年 | 2551篇 |
1993年 | 2049篇 |
1992年 | 1805篇 |
1991年 | 1713篇 |
1990年 | 1364篇 |
1989年 | 1453篇 |
1988年 | 1277篇 |
1987年 | 1069篇 |
1986年 | 1119篇 |
1985年 | 895篇 |
1984年 | 755篇 |
1983年 | 712篇 |
1982年 | 750篇 |
1981年 | 579篇 |
1980年 | 549篇 |
1979年 | 440篇 |
1978年 | 454篇 |
1977年 | 510篇 |
1975年 | 354篇 |
1972年 | 345篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
991.
Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf® ) in the treatment of lower-extremity ulcers 总被引:1,自引:0,他引:1
Joseph Cavorsi MD FACS ; Frank Vicari MD FACS FAAP ; Douglas J. Wirthlin MD FACS ; William Ennis DO MBA FACOS ; Robert Kirsner MD ; Sean M. O''Connell PhD ; John Steinberg DPM ; Vincent Falanga MD 《Wound repair and regeneration》2006,14(2):102-109
Tissue-engineered skin substitutes such as Apligraf have emerged over the past 20 years as among the most carefully studied and efficacious of the advanced wound modalities. These products have been proven as effective enhancements to general wound care, promoting wound closure particularly in instances where conventional wound care fails. Marketed for hard-to-heal wounds since 1998, Apligraf has become part of standard wound care in many wound centers across the United States. Despite this situation, few general wound care guidelines incorporate advanced and active wound-healing technologies, such as tissue-engineered skin products. Because of this deficiency, appropriate patient selection and proper use of these product remain largely unaddressed within the general wound care community. Here, we describe the development of guidelines surrounding optimal use of the bilayered living cell therapy, Apligraf, in the treatment of the two types of lower extremity ulcers for which the product is FDA approved: venous leg ulcer and diabetic foot ulcer. The guidelines detailed in this article focus on the identification and selection of patients who are at risk for failure of standard wound care therapy and thus appropriate for Apligraf treatment. The intended audience for these guidelines is the general wound care practitioner, for whom the developed treatment algorithms and accompanying figure legends should provide practical, user-friendly direction simplifying both patient selection and appropriate use of Apligraf within the context of good wound-healing practice. 相似文献
992.
993.
Jean-Pierre Chanoine MD PhD Sarah Hampl MD FAAP Craig Jensen MD Mark Boldrin MS Jonathan Hauptman MD 李呈亿 《美国医学会杂志》2006,25(1):34-43
背景:儿童和青少年超重和肥胖正迅速增加。在该人群,单纯行为疗法减肥及维持体重下降的效果有限,但是对药物治疗尚未进行广泛的研究。
目的:确定奥利州他(Orlistat)在青少年体重治疗方面的效果及其安个性。
设计、地点和病例:于美国和加拿大32个中心、539例肥胖青少年(12—16岁;体重指数[body mass index,BMI]在第95百分化之上≥2单位)进行的多ln0、54剧(2000年8月至2002年10月)随机双盲研究。
干预:给予奥利司他(n=357)或安慰剂(n=182)120mg,每口3次,持续1年;加适度低热卡饮食(脂肪占30%)、运动和行为治疗。
主要观察指标:BMI变化;二级指标包括腰围和髋用、体重下降、脂质测量以及机体对口服葡萄糖的血糖和胰岛素反心。
结果:至12周时,两组BMI均有下降;此后,奥利司他组体重维持稳定而安慰剂组则超过基线。研究结束时,奥利司他组BMI下降0.55。而安慰剂组则增加0.31(P=0.001)。与安慰剂组的15.7%相比,奥利司他组26.5%的病例BMI下降≥5%(P=0.005);BMI下降≥10%者分别为4.5%和13.3%(P=0.002)。在研究结束时,奥利司他组体重增加0.53kg,安慰剂组增加3.14kg(P〈0.001)。双能X线吸收测量娃示,这种差异可用脂肪体再的变化解释。奥利司他组腰围下降,安慰剂组腰围上升(-1.33cm比+0.12cm;P〈0.05)。奥利司他组发生轻至中度胃肠道不良事件者为9%-50%,安慰剂组为1%~13%。
结论:与安慰剂比较,奥利司他与饮食、运动和行为改善联合可显著改善肥胖青少年体重的治疗。在这个青少年人群,连续使用奥利司他1年并无重要安全问题,尽管奥利司他组胃肠道不良事件较为常见。 相似文献
994.
Intracranial Angioplasty and Stenting in the Awake Patient 总被引:1,自引:0,他引:1
Alex Abou-Chebl MD Derk W. Krieger MD Christopher T. Bajzer MD Jay S. Yadav MD FACC 《Journal of neuroimaging》2006,16(3):216-223
BACKGROUND AND PURPOSE: Endovascular treatment for intracranial atherosclerosis is evolving, but complications remain an issue. Most interventions are performed under general anesthesia, preventing intraprocedural clinical evaluations. We describe our approach to intracranial angioplasty and stenting, using local rather than general anesthesia, and intraprocedural neurological assessment. METHODS: We prospectively collected procedural and outcome information on all patients undergoing intracranial angioplasty and stenting. Patients underwent interventions under local anesthesia with mild intravenous sedation or analgesia only if needed. Intraoperative neurological evaluations were performed, and symptomatology was used to guide the interventional technique. RESULTS: Forty-eight arteries in 40 patients with a mean age of 65.2 years were treated. Thirty-two anterior and 16 posterior circulation segments were treated. Technical success was achieved in 100% of patients with reduction of the mean pretreatment stenosis from 85 +/- 8.6% to 7 +/- 10.1%. Stents were deployed in 40 segments; five patients were treated with drug-eluting stents. The cobalt-chromium coronary stents were the easiest to deliver. Thirty-seven patients were treated under local anesthesia and, of those, 61.4% experienced intraprocedural symptoms that led to some alteration of the interventional technique. Headache was the most common symptom, and, when persistent, it heralded the occurrence of subarachnoid hemorrhage. There were seven total neurological complications, but only five (10.5%) led to permanent morbidity (4 strokes) or mortality (1 death). CONCLUSIONS: Intracranial angioplasty and stenting can be successfully performed using coronary techniques and equipment including drug-eluting stents. Local anesthesia permits neurological evaluations and often leads to the adjustment of the interventional technique, potentially making the procedure safer. 相似文献
995.
996.
997.
998.
999.
1000.
Leonardo Bonilha MD PhD Paulien M. de Vries Diana J. Vincent MD PhD Chris Rorden MD PhD Paul S. Morgan Mark W. Hurd PhD Nada Besenski MD Kenneth J. Bergmann MD Vanessa K. Hinson MD PhD 《Movement disorders》2007,22(8):1110-1116
We investigated whether structural white matter abnormalities, in the form of disruption of axonal coherence and integrity as measured with diffusion tensor imaging (DTI), constitute an underlying pathological mechanism of idiopathic dystonia (ID), independent of genotype status. We studied seven subjects with ID: all had cervical dystonia as their main symptom (one patient also had spasmodic dysphonia and two patients had concurrent generalized dystonia, both DYT1‐negative). We compared DTI MR images of patients with 10 controls, evaluating differences in mean diffusivity (MD) and fractional anisotropy (FA). ID was associated with increased FA values in the thalamus and adjacent white matter, and in the white matter underlying the middle frontal gyrus. ID was also associated with increase in MD in adjacent white matter to the pallidum and putamen bilaterally, left caudate, and in subcortical hemispheric regions, including the postcentral gyrus. Abnormal FA and MD in patients with ID indicate that abnormal axonal coherence and integrity contribute to the pathophysiology of dystonia. These findings suggest that ID is not only a functional disorder, but also associated with structural brain changes. Impaired connectivity and disrupted flow of information may contribute to the impairment of motor planning and regulation in dystonia. © 2006 Movement Disorder Society 相似文献